Results 11 to 20 of about 152,699 (284)
Data on drug–drug interactions (DDI) of antineoplastic drugs with anticoagulants is scarce. We aim to evaluate factors associated with DDI of antineoplastic and supportive care drugs with anticoagulants resulting in modification of pharmacokinetics of ...
Érique José F. Peixoto de Miranda MD, PhD +6 more
doaj +2 more sources
Infiltrative Lung Diseases: Complications of Novel Antineoplastic Agents in Patients with Hematological Malignancies [PDF]
Infiltrative lung disease is a well-known complication of antineoplastic agents in patients with hematological malignancies. Novel agents are constantly being added to available treatments.
Bobbak Vahid, Paul E Marik
doaj +2 more sources
Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation. [PDF]
PurposeOur goal was to identify new anticancer agents approved by the US Food and Drug Administration (FDA) and the European Medical Agency (EMA) since the 2016 MASCC/ESMO antiemetic update and classify their emetic potential.MethodsThe MASCC/ESMO Expert
Jordan K +7 more
europepmc +2 more sources
Objective: Resistance to anticancer agents ensures a poor prognosis in patients with lung cancer. Metformin could enhance the anticancer effects of standard antineoplastic agents [traditional chemotherapy drugs, epidermal growth factor receptor tyrosine ...
Xiaofeng Luo +8 more
doaj +1 more source
Background Permeability of antineoplastic agents through medical gloves is an important factor that must be considered for the appropriate selection of gloves.
Toyohito Oriyama +6 more
doaj +1 more source
Objectives: Non-small cell lung cancer (NSCLC) accounts for 75–85% of all lung cancer diagnoses. This meta-analysis sought to estimate the overall survival (OS) of NSCLC based on randomized control trials which had compared docetaxel with kinase ...
Chaitra Nagaraju +10 more
doaj +1 more source
Evaluating New Antineoplastic Agents [PDF]
exaly +3 more sources
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents. [PDF]
20.500.12530/87858Our objectives were to analyze the use of complementary and alternative medicine (CAM) in cancer patients and to describe the incidence and characteristics of interactions between CAM and antineoplastic agents.
Escudero-Vilaplana V +11 more
europepmc +2 more sources
Antineoplastic agents and the liver
During the last two decades, the use of chemotherapeutic agents in the treatment of cancer and diverse medical conditions has grown steadily. The introduction into the pharmacologic armamentarium of a number of drugs whose pharmacokinetics, metabolism, and mode of action are in most cases poorly understood has not however been without causing problems ...
D B, Ménard +4 more
openaire +2 more sources
Cytotoxic Activity of Antineoplastic Agents on Fertility: A Systematic Review [PDF]
Objective: To analyze the long-term effects of antineoplastic treatments on patient fertility. Selection of Studies: The studies were selected through the New PubMed, Scielo and Lilacs databases along with references used for the creation of the present
Gabriel Acácio de Moura +1 more
doaj +1 more source

